(Q37019841)

17 August 2017

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer (English)

1 reference

17 August 2017

1 reference

David J Gallagher

1

0 references

Tomas Kirchhoff

Tomas Kirchhoff

4

0 references

Michael J. Morris

Michael J Morris

12

0 references

Mark Robson

Mark E Robson

18

0 references

Larry Norton

Larry Norton

15

0 references

Michael J Zelefsky

Michael Zelefsky

11

0 references

Kenneth Offit

19

Kenneth Offit

1 reference

17 August 2017

2

Mia M Gaudet

1 reference

17 August 2017

8

Zsofia Stadler

1 reference

17 August 2017

13

Howard I Scher

1 reference

17 August 2017

Prodipto Pal

3

1 reference

17 August 2017

Lisa Balistreri

5

1 reference

17 August 2017

Kinjal Vora

6

1 reference

17 August 2017

Jasmine Bhatia

7

1 reference

17 August 2017

Samson W Fine

9

1 reference

17 August 2017

Victor Reuter

10

1 reference

17 August 2017

Robert J Klein

14

1 reference

17 August 2017

James A Eastham

16

1 reference

17 August 2017

Peter T Scardino

17

1 reference

17 August 2017

language of work or name

English

0 references

publication date

9 March 2010

1 reference

17 August 2017

Clinical Cancer Research

1 reference

17 August 2017

16

1 reference

17 August 2017

7

1 reference

17 August 2017

2115-2121

1 reference

Induced chromosomal proximity and gene fusions in prostate cancer

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Prostate cancer genomics: towards a new understanding

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Drug resistance caused by reversion mutation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Rapid progression of prostate cancer in men with a BRCA2 mutation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Clinical practice. Management of an inherited predisposition to breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

The New York Cancer Project: rationale, organization, design, and baseline characteristics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Cancer Incidence in BRCA1 mutation carriers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. 1974

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

NCCN Practice Guidelines for Prostate Cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Cancer risks in BRCA2 mutation carriers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

BRCA mutations and risk of prostate cancer in Ashkenazi Jews

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

The Effects of Common Genetic Variants in Oncogenes on Ovarian Cancer Survival

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713614

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

4 December 2018

1 reference

12 December 2020

Trends in prostate cancer mortality among black men and white men in the United States

1 reference

12 December 2020

Clinical states in prostate cancer: toward a dynamic model of disease progression

1 reference

12 December 2020

Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies

1 reference

12 December 2020

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

1 reference

12 December 2020

Prognostic features in men who died of prostate cancer

1 reference

12 December 2020

Jewish ethnicity and prostate cancer mortality in two large US cohorts

1 reference

12 December 2020

10.1158/1078-0432.CCR-09-2871

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

20215531

1 reference